In a stunning admission, a leading figure at Pfizer stated in early October that the company did not know whether its "vaccine" or "shot," developed with BioNTech, would prevent transmission of the virus that reportedly causes COVID-19 before it entered the market in December 2020.
- Janine Small, Pfizer's president of international development markets, testified before the European Parliament's special committee on COVID–19 after the company's CEO Dr. Albert Bourla pulled out of his appointment to testify.
No justification for COVID passport scheme
- This scheme was forced upon E.U. residents and citizens when introduced in July 2021
- Many were sold on the idea that the inoculated were protected from becoming sick with COVID-19
- Even Bourla admitted it was unclear whether inoculated people could transmit SARS-CoV-2 in a December 2020 interview with NBC News
- Roos, alongside a relatively small group of MEPs, has consistently vocalized opposition to COVID passports
How the COVID shots were sold to Americans
- The shots were developed by Pfizer-BioNTech and granted emergency use authorization (EUA) in the United States in December 2020
- Later, the Food and Drug Administration (FDA) fully approved this product marketed as 'Comirnaty' for individuals aged at least 16 years old in August 2021 and for children 12 through 15 in July 2022
Endpoint of Pfizer’s “vaccine” clinical study
- One of the primary endpoints included efficacy against a COVID-19 “incidence” or case at least 7 days after the second jab as confirmed after laboratory-based testing.
- The other three secondary endpoints were: efficacy against an “infection” (positive SARS-CoV-2) following a viral diagnostic test, such as reverse transcription polymerase chain reaction (RT-PCR), within 4 days of a symptomatic period (e.g. fever, new or increased cough, shortness of breath, chills, fever, muscle pain, sore throat, diarrhea, vomiting) and additional symptoms as defined by the CDC.
Changes to definitions
- The purpose of vaccination has been modified
- Defined by the CDC as late as 2018, its age-old purpose is "the act of introducing a vaccine into the body to produce immunity to a specific disease." Yet, the latest definition substitutes 'protection' for 'immunity.'
- Moreover, the term "vaccine" has changed to the latest "a preparation that is used to stimulate the immune response against diseases."
Updates from "public health experts"
- CDC has updated its recommendation that COVID-19 vaccines be given to everyone 6 months and older, and boosters for 5 years and older if eligible
A snapshot of Pfizer's revenue
- Between 2011-2012, 2014-2015 and 2020 alone, Pfizer was persistently in the red negative for year-over-year (YoY) quarterly growth.
- In 2021, the company hit a double whammy with annual revenue of around $81 billion, and since then, it has been on a roll.
What did leading U.S. figures tell Americans?
- President Joe Biden said in July 2021, "You're not going to get COVID if you have these vaccinations."
- However, he tested positive for SARS-CoV-2 a year later despite being fully jabbed with booster shots.
- The White House's medical advisor and director of the National Institute of Allergy and Infectious Diseases Dr. Anthony Fauci-who is to step down in December after more than 50 years at the National Institutes of Health-has also given statements on the COVID shots' efficacy akin to a rollercoaster ride
- Even though there are "breakthrough infections" in jabbed individuals, the level of COVID-19 in their body is so low that it is "extremely unlikely" they will transmit it
- jabbed people become "dead ends" for coronavirus to spread
Studies show waning effectiveness of COVID shots
- Some studies have shown that the efficacy of the COVID vaccine dropped between 35% and 85% after 3 months of use, and it lost effectiveness in protecting against death in veterans 65+
- A solution would be to implement public health interventions such as strategic testing for control of outbreaks, vaccine passports, employment-based vaccine mandates, vaccination campaigns for eligible children and adults, and consistent messaging from public health leadership
Why Pfizer's CEO was scheduled to testify in the first place
- The decision followed after the European Court of Auditors published a report in mid-September raising eyebrows and questions about communication between Bourla and the E.U. chief, a.k.a. European Commission President Ursula von der Leyen regarding a contract worth multibillions of euros
- Since then, the European Public Prosecutor's Office (EPPO) has opened an investigation into the EU's COVID shots purchases
No comments:
Post a Comment